T2 Biosystms Inc
T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2… Read more
T2 Biosystms Inc (TTOO) - Total Liabilities
Latest total liabilities as of September 2024: $29.79 Million USD
Based on the latest financial reports, T2 Biosystms Inc (TTOO) has total liabilities worth $29.79 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
T2 Biosystms Inc - Total Liabilities Trend (2012–2023)
This chart illustrates how T2 Biosystms Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
T2 Biosystms Inc Competitors by Total Liabilities
The table below lists competitors of T2 Biosystms Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BMEX Gold Inc
OTCQB:MRIRF
|
USA | $480.39K |
|
DOMINION RES
MU:DOD
|
Germany | €72.29 Billion |
|
CHEESECAKE FACTORY (CF2.SG)
STU:CF2
|
Germany | €2.54 Billion |
|
Bespoke Extracts Inc
OTCQB:BSPK
|
USA | $2.89 Million |
|
Tortoise Energy Infrastructure Closed Fund
NYSE:TYG
|
USA | $304.75 Million |
Liability Composition Analysis (2012–2023)
This chart breaks down T2 Biosystms Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how T2 Biosystms Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for T2 Biosystms Inc (2012–2023)
The table below shows the annual total liabilities of T2 Biosystms Inc from 2012 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $62.83 Million | -15.50% |
| 2022-12-31 | $74.36 Million | +1.25% |
| 2021-12-31 | $73.44 Million | +4.39% |
| 2020-12-31 | $70.35 Million | +12.58% |
| 2019-12-31 | $62.49 Million | +18.08% |
| 2018-12-31 | $52.92 Million | -1.12% |
| 2017-12-31 | $53.52 Million | +6.55% |
| 2016-12-31 | $50.23 Million | +25.55% |
| 2015-12-31 | $40.01 Million | +54.95% |
| 2014-12-31 | $25.82 Million | -78.74% |
| 2013-12-31 | $121.43 Million | +63.89% |
| 2012-12-31 | $74.09 Million | -- |